Jay R. Luly, Ph.D. 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:05 pm Purchase | 2025-02-12 | 13D | Enanta Pharmaceuticals, Inc. ENTA | Jay R. Luly, Ph.D. | 1,703,616 7.700% | 337,298 (+24.69%) | Filing |
| 2021-12-17 4:31 pm Purchase | 2021-12-15 | 13D | Enanta Pharmaceuticals, Inc. ENTA | Jay R. Luly, Ph.D. | 1,366,318 6.500% | 176,529 (+14.84%) | Filing |